Diabetes Care, Vol 20, Issue 3 392-395, Copyright © 1997 by American Diabetes Association

ARTICLES

Granulocyte function in women with diabetes and asymptomatic bacteriuria

D Balasoiu, KC van Kessel, HJ van Kats-Renaud, TJ Collet and AI Hoepelman
County Hospital Timisoara, Romania.

OBJECTIVE: To study whether diabetic women with asymptomatic bacteriuria have impaired granulocyte function and compare them with nonbacteriuric diabetic women. RESEARCH DESIGN AND METHODS: A prevalence study with granulocyte function testing in a randomly selected number of patients was conducted; the setting was the university. The patients consisted of 63 women visiting the outpatient clinic for routine control of their diabetes. Measurements of routine blood controls and urine cultures were conducted in all patients. Granulocyte function testing (chemotaxis, opsonization, oxidative burst, phagocytosis, and killing) was performed in the first 20 patients (10 with and 10 without asymptomatic bacteriuria) and in 7 healthy control subjects. RESULTS: The prevalence of bacteriuria was 32%. Demographic characteristics were not significantly different between bacteriuric and nonbacteriuric women. Leukocytes were found more often in the urine of bacteriuric women (P < 0.05). No differences in any of the granulocyte function tests were documented among diabetic women with true asymptomatic bacteriuria, nonbacteriuric women, and healthy control subjects. CONCLUSIONS: The prevalence of asymptomatic bacteriuria is increased in women with diabetes. Granulocyte function impairment, however, cannot be the explanation for this finding.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. A. Rosen, C.-S. Hung, K. A. Kline, and S. J. Hultgren Streptozocin-Induced Diabetic Mouse Model of Urinary Tract Infection Infect. Immun., September 1, 2008; 76(9): 4290 - 4298. [Abstract] [Full Text] [PDF]

				J. S. Brown, H. Wessells, M. B. Chancellor, S. S. Howards, W. E. Stamm, A. E. Stapleton, W. D. Steers, S. K. Van Den Eeden, and K. T. McVary Urologic Complications of Diabetes Diabetes Care, January 1, 2005; 28(1): 177 - 185. [Full Text] [PDF]

				S. E. Geerlings, R. Meiland, E. C. van Lith, E. C. Brouwer, W. Gaastra, and A. I.M. Hoepelman Adherence of Type 1-Fimbriated Escherichia coli to Uroepithelial Cells: More in diabetic women than in control subjects Diabetes Care, August 1, 2002; 25(8): 1405 - 1409. [Abstract] [Full Text] [PDF]

				Y. Nazligul, T. Sabuncu, and H. Ozbilge Is There a Predisposition to Intestinal Parasitosis in Diabetic Patients? Diabetes Care, August 1, 2001; 24(8): 1503 - 1504. [Full Text] [PDF]

				M. C. Verhaar, M. L.H. Honing, T. van Dam, M. Zwart, H. A. Koomans, J. J.P. Kastelein, and T. J. Rabelink Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids Cardiovasc Res, June 1, 1999; 42(3): 752 - 760. [Abstract] [Full Text] [PDF]

				M. C. Verhaar, R. M. F. Wever, J. J. P. Kastelein, T. van Dam, H. A. Koomans, and T. J. Rabelink 5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia Circulation, January 27, 1998; 97(3): 237 - 241. [Abstract] [Full Text] [PDF]